MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$22,047K
Investment in marketable
securities
$17,600K
Prepaid and other
current assets
$4,696K
Operating lease
right-of-use assets
$32K
Non-current prepaid
expenses and other assets
$241K
Property and equipment,
net
$102K
Total current assets
$44,343K
Total non-current
assets
$375K
Total assets
$44,718K
Total liabilities and
stockholders equity
$44,718K
Total stockholders'
equity
$38,882K
Total liabilities
$5,836K
Accumulated other
comprehensive (loss) income
-$2K
Accumulated deficit
-$745,536K
Additional paid-in capital
$784,418K
Total current
liabilities
$5,836K
Common stock 0.0001 par
value 150,000,000...
$2K
Trade payables
$1,414K
Accrued expenses
$3,578K
Employee related
obligations
$819K
Operating lease
liabilities
$25K
Back
Back
Balance Sheet
source: myfinsight.com
VYNE Therapeutics Inc. (VYNE)
VYNE Therapeutics Inc. (VYNE)